domingo, 8 de octubre de 2017

BioEdge: Will assisted suicide always provide a quick and gentle death?

BioEdge: Will assisted suicide always provide a quick and gentle death?

Will assisted suicide always provide a quick and gentle death?
The gold standard for human experimentation is a randomly-assigned double-blind placebo-controlled study. Unfortunately, organising such a study to assess the effectiveness of the lethal medications used for executions in the United States and for physician-assisted suicide (PAS) has significant ethical issues. We need to rely upon historical data.

In the latest issue of the Journal of Law and the Biosciences, Sean Riley, an end-of-life researcher currently studying in the Netherlands reviews the patchy record of the drugs used in executions and PAS. He summarises his findings as follows:

The pervasive belief that these, or any, noxious drugs are guaranteed to provide for a peaceful and painless death must be dispelled; modern medicine cannot yet achieve this. Certainly some, if not most, executions and suicides have been complication-free, but this notion has allowed much of the general public to write them off as humane, and turn a blind eye to any potential problems. Executions or PAS have never been as clean as they appear, even with the US’s medicalization efforts during the 1980s.
He discusses several issues:

Supplier boycotts. Under pressure from anti-death penalty activists, pharmaceutical companies refused to supply prisons with lethal medications. Efforts to circumvent this by going to shady middlemen eventually failed. Most states have ceased to import the key ingredients needed for executions.

Price gouging for PAS drugs. Because of the drought of lethal medications for executions, the price of secobarbital or pentobarbital for PAS has skyrocketed. “Before 2012, patients would pay about $500 for a sufficient lethal dose of the drug, but by 2016, prices had inflated to figures upwards of $25,000.”

Compounding pharmacies. Faced with the huge cost of assisted suicide, prisons and patients began to turn to compounding pharmacies where pharmacists create the drugs from raw materials. “As the past 3 or so years have seen a dramatic increase in the use of compounded drugs,” writes Riley. “There has been a corresponding rise in ‘botched’ executions, though the secrecy laws have neutered most attempts to link failed executions to compounded drugs.”

The drugs made in compounding pharmacies risk being subpotent, superpotent, or contaminated. In Massachusetts a former pharmacist is on trial for supplying contaminated drugs which caused a nationwide outbreak of meningitis. Prosecutors told the court that he had used expired ingredients, falsified documents, neglected cleaning, failed to properly sterilize the drugs, shipped products before they were tested and ignored mould and bacteria in manufacturing areas.

PAS complications and botched executions. It is difficult to define what a “botched execution” is, but the last moments of some prisoners were clearly agonising. And for PAS, there is a lack of data. “According to data published by Oregon, 5% of patients experienced difficulties, such as regurgitation or seizures, after ingestion of the medication, since the inception of the law in 1997,” says Riley. However, in only 51% of the cases were the details reported. And “there are six reported instances where patients ingested the lethal medications, went unconscious, and awoke sometimes days later.”

Riley concludes that “The processes of death will always, to some extent, be a mystery. For now, whether a death is peaceful and painless can only be assumed.”


Sunday, October 8, 2017

The drugs used for executing American prisoners and the drugs used for assisting suicide are more or less the same. Do they guarantee that patients will, as in Keats' poem, "cease upon the midnight with no pain".

Um, no, or at least no guarantees. Just as some prisoners are tormented in botched executions, some patients in the state of Oregon have taken the lethal drug, gone unconscious, and awakened -- sometimes days later. Read all about it in our lead article.

Michael Cook
 Comment on BioedgeFind Us on FacebookFollow us on Twitter
by Michael Cook | Oct 07, 2017
No, sorry, not always
by Michael Cook | Oct 07, 2017
Challenge to Suicide Act 1961 fails
by Michael Cook | Oct 07, 2017
From ensoulment to reincarnation
by Michael Cook | Oct 07, 2017
Kazuo Ishiguro discussed cloning and organ donation in his 2005 novel
by Michael Cook | Oct 07, 2017
It's about time, some will say
by Michael Cook | Oct 07, 2017
Sleazy marketing tactics are popular in a competitive field
by Michael Cook | Oct 07, 2017
As long as they are competent, their requests will be binding
by Xavier Symons | Oct 07, 2017
There are ethical concerns about business practices of genomics companies
by Xavier Symons | Oct 07, 2017
Two Canadian ethicists defend a moratorium on embryo gene-editing, arguing that it reflects an international consensus
by Michael Cook | Oct 07, 2017
There are several quasi-religious organisations now operational in Silicon Valley
Phone: +61 2 8005 8605
Mobile: 0422-691-615

No hay comentarios: